Strides Shasun Gets USFDA Go-Ahead For Anti-Allergy Drug Business Business / Business 6 years ago 345 Views comments Citing IMS sales data, Strides Shasun said the US market for the approved product is approximately $17 million. Read more
Business Tata Motors, Tata Chemical, Tata Beverages shares surge; 8.6 crore shares transferred Business / Business - 6 years ago
Business Tata looking to sell out underperforming companies | Tata अंडर परफॉर्म कंपनियों को बेच सकती है Business / Business - 6 years ago
Business Fast Money: Know top 20 trade options of the day to keep in your portfolio (Part-1) Business / Business - 6 years ago
Business No GST on gifts up to Rs 50,000 by employer: Finance Ministry Business / Business - 6 years ago
Business Allegations against Chief Justice of India by top SC judges Business / Business - 6 years ago
Comments